FormWeb • panobinostat

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

panobinostat

panobinostat

Non-formulary Anti-Neoplastic Formulary

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Farydak	CAPSULE, ORAL	10 mg, 15 mg, 20 mg

Comments:

Oral Chemotherapy Drug Pharmacist Education

Oral Chemotherapy TOC Information

Farydak medication guide

Farydak -- Oral drug used for treatment of resistant multiple myeloma, rare inpatient use expected. Non-formulary, not stocked, patient may use own supply in hospital.

Reviewed: 25 August 2015 (Farydak)

REMS (Farydak): View FDA REMS Info

Last updated: Apr. 11, 2024

Black Box Warning: Fatal and serious toxicities; severe diarrhea and cardiac toxicities
HAZ-MED: Group 1
Chemotherapy:

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.